SRP54

Signal recognition particle subunit SRP54 · P61011 · SRP54 on Sugi Atlas →

0 patent compounds predicted against SRP54, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRP54 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 PHASE3ACTIVE_NOT_RECRUITING
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Testing of Micellar Casein, Blended Micellar Casein and Native Whey nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations nanUNKNOWN
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SRP54 binder may also engage these)

ProteinNameSimilarity
P14576 1.000 P14576 →
Q5R4R6 1.000 Q5R4R6 →
P61010 1.000 P61010 →
Q7ZVN5 1.000 Q7ZVN5 →
Q6AYB5 1.000 Q6AYB5 →
Q2T9U1 1.000 Q2T9U1 →
Q4R965 1.000 Q4R965 →
P49968 1.000 P49968 →
P20424 0.999 P20424 →
P49969 0.999 P49969 →
P21565 0.999 P21565 →
P49970 0.998 P49970 →
P49972 0.998 P49972 →
P37106 0.998 P37106 →
P49971 0.996 P49971 →
Q8MZJ6 0.996 Q8MZJ6 →
P49967 0.996 P49967 →
Q75K18 0.995 Q75K18 →
Q99150 0.994 Q99150 →
Q0W2G1 0.994 Q0W2G1 →
A5UMY7 0.994 A5UMY7 →
Q00179 0.994 Q00179 →
P49966 0.993 P49966 →
Q9ZK62 0.993 Q9ZK62 →
Q6LX03 0.992 Q6LX03 →
P56005 0.992 P56005 →
O42816 0.992 O42816 →
A6UQJ8 0.992 A6UQJ8 →
Q46E01 0.992 Q46E01 →
O15821 0.992 O15821 →